COVID-19 therapeutics
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …
has been studied and deployed. Healthcare providers have multiple treatment approaches …
[HTML][HTML] Antiviral agents for the treatment of COVID-19: Progress and challenges
M Singh, E de Wit - Cell Reports Medicine, 2022 - cell.com
The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …
unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in …
[HTML][HTML] Urgent needs to accelerate the race for COVID-19 therapeutics
On December 8, 2020, a 91-year-old woman made history as the first person to receive the
COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time …
COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time …
[HTML][HTML] Therapeutic options for Coronavirus Disease 2019 (COVID-19): where are we now?
EY Golnabi, JM Sanders, ML Johns, K Lin… - Current Infectious …, 2021 - Springer
Abstract Purpose of Review Rapidly evolving treatment paradigms of coronavirus disease
2019 (COVID-19) introduce challenges for clinicians to keep up with the pace of published …
2019 (COVID-19) introduce challenges for clinicians to keep up with the pace of published …
Antiviral therapy of COVID-19
SM Janković - Scripta Medica, 2020 - aseestant.ceon.rs
The COVID-19 pandemic required rapid response to the needs of critically ill patients, and
one of the solutions was re-purposing of drugs with wide spectrum of antiviral action for …
one of the solutions was re-purposing of drugs with wide spectrum of antiviral action for …
Treating COVID-19: are we missing out the window of opportunity?
J Sundararaj Stanleyraj, N Sethuraman… - Journal of …, 2021 - academic.oup.com
Severe COVID-19 is a biphasic illness, with an initial viral replication phase, followed by a
cascade of inflammatory events. Progression to severe disease is predominantly a function …
cascade of inflammatory events. Progression to severe disease is predominantly a function …
[HTML][HTML] Treatment options for COVID-19: a review
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
worldwide. Due to the limited evidence available on the dynamics of the virus and effective …
Current perspective of antiviral strategies against COVID-19
COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …
This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe …
Coronavirus disease 2019 treatment: a review of early and emerging options
EK McCreary, JM Pogue - Open forum infectious diseases, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time …
Safety and Efficacy of antiviral drugs against covid-19 infection: an updated systemic review
AMR Al-juhaishi, ND Aziz - Medical and Pharmaceutical Journal, 2022 - pharmacoj.com
SARS-CoV-2 infection is an acute pneumonia attack caused by a largely-infectious, recently
elicited, and murdered virus with global public health issues and economic problems. Many …
elicited, and murdered virus with global public health issues and economic problems. Many …